Statistics

Total Visits

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)8

Select a period of time:

Number of views in the range

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)3

Views

Views
November 20231
December 20230
January 20241
February 20240
March 20240
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Ashburn1
Boardman1